Antiretroviral therapy in intensive care

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pharmacology

Background:

• Antiretroviral therapy (ART) use in intensive care units (ICUs) poses significant challenges.
• Common issues include drug administration, altered pharmacokinetics in ventilated patients, drug interactions, and immune reconstitution inflammatory syndrome (IRIS).

Purpose of the Study:

• To review the frequent issues associated with ART use in the ICU.
• To provide guidance on managing these challenges for ICU physicians.

Main Methods:

• Literature review of studies on ART management in ICU settings.
• Analysis of challenges and proposed solutions for ART administration and monitoring.

Main Results:

• Many ICU physicians stop ART upon admission and are hesitant to initiate it during the ICU stay.
• Literature suggests earlier ART initiation leads to better efficacy.
• Stopping ART can be detrimental for certain patient populations.

Conclusions:

• Despite challenges, continuing or initiating ART early in the ICU is crucial.
• Effective management strategies are needed to overcome ART-related issues in critically ill patients.
• Optimizing ART in the ICU setting can improve patient outcomes and reduce risks.